At the beginning of the COVID-19 (SARS-CoV-2) pandemic, it was not clear which patients would be most at risk, although it was soon realised that older age was a major risk factor and that there was a high incidence of coagulation disorders and thrombosis associated with COVID-19 infection.1 For clinicians managing PWH, and for the patients themselves, it was not known whether this would reduce, increase or have no impact in PWH. It soon became apparent that the risk of infection and severe disease in the general population was greater in older adults. Adults > 65 years of age represented 80% of hospitalizations and had a 23-fold greater risk of death than those < 65 years old.[...]
Hermans, C., Astermark, J., Carvalho, M., Dolan, G., d’Oiron, R., Fontana, P., Holme, P. A., Kenet, G., Klamroth, R., Mancuso, M. E., Marquardt, N., Nunez, R., Katsarou, O., Pabinger-Fasching, I., Quintavalle, G., Rodgers, R., van der Valk, P., Windyga, J., Jimenez Yuste, V., & Preložnik Zupan, I. (2023). Prevalence of COVID-19 related hospitalizations and mortality in adults aged ≥40 years with haemophilia: A survey from Europe. Haemophilia (Print), 29(3), 913-916. https://doi.org/10.1111/hae.14761 (Original work published 2023)